Caitlin Hirschman, R.N.

Executive Director, Project Delivery

Caitlin Hirschman, R.N.

Executive Director, Project Delivery

Caitlin Hirschman has over 20 years of clinical research experience across Phase 1-4 studies in a variety of therapeutic areas including pulmonology and has spent the last 10+ years working with cystic fibrosis. She has successfully provided oversight and clinical trial management support for over 10 cystic fibrosis studies, including multiple U.S. and global programs.

Ms. Hirschman’s cystic fibrosis-related research experience has included treatment with aerosolized products and oral therapies, as well as inpatient and PK studies. Always looking to better serve her clients, Ms. Hirschman and her team consistently involved themselves in quarterly meetings with the CFF TDN as a result of her collaboration with the organization over the last 5+years. She has attended NACFC for the past 6 years and has been involved with a variety of CF functions in the Triangle, including The Brewer’s Ball and Master Chefs.

Prior to joining Rho as a Clinical Team Lead, Ms. Hirschman held the positions of Clinical Research Associate (CRA), Senior CRA, Lead CRA, Clinical Team Lead, Senior Clinical Team Lead, and Global Clinical Lead. Over the course of her career, Ms. Hirschman has led and/or been involved with the following: site identification and selection, management of CRAs – including leadership of multiple global clinical study teams, development of clinical protocols, case report and other data collections forms, informed consent forms, site and monitor training tools, and clinical monitoring plans.

Prior to her clinical research career, Ms. Hirschman practiced as a Registered Nurse in the Medical Intensive Care Unit, where she built a strong knowledge base in a large number of medical therapeutic areas including pulmonology, gastroenterology, cardiology, immunology, endocrinology, hematology, and infectious diseases.

Ms. Hirschman received her BSN from the University of Virginia in Charlottesville, and a BS in Exercise Physiology and Nutrition from the University of Massachusetts in Amherst.

Why Cystic Fibrosis?

“For me, with the incredible amount of positive medical advancements since I began working in CF almost 10 years ago, it’s hard not to be passionate about the disease. The CF Foundation and community are so involved and provide such incredible support, I am lucky to be just a small part of something so big. And thanks to Rho, I have been able to attend the national CF conference for the past 4 years and witness first-hand the developments and positivity at these conferences.”

This is what drives Caitlin:

“I am a self-motivated person driven to do the very best in every aspect of my professional and personal lives (though there are times when I don’t always achieve what I’d hoped due to extenuating circumstances). At this point in my career, I aim to be a mentor and a leader, and I hope to share my wisdom and experiences with younger and less experienced folks. As long as I can do that, I will be doing what makes me happy.”

Content by Caitlin Hirschman, R.N.


Building Bridges: Patient Advocacy Groups Can Be Vital Partners in Clinical Research Trials

Patient advocacy is vital for advancement in managing disease. We met with Chandrabali Ghose-Paul, Chief Scientific Officer, Emily’s Entourage and Gary Joyner, Chairman Emeritus, Board of Directors, Primary Ciliary Dyskinesia (PCD) Foundation to discuss the role of patient advocacy groups in clinical research. In this webinar, we discuss building the gap between research and patients and how to support patient advocacy in our community.


Not Just Tiny Humans: Conducting Pediatric Clinical Trials

From study design to logistics to recruitment, there are key differences between studies in pediatric populations and studies in adult populations. This webinar examines what it takes to successfully conduct a pediatric clinical trial.